tiprankstipranks
Advertisement
Advertisement
OncoSil on track for TRIPP-FFX data as it targets broader EU approval for pancreatic cancer device
PremiumCompany AnnouncementsOncoSil on track for TRIPP-FFX data as it targets broader EU approval for pancreatic cancer device
29d ago
OncoSil Seeks ASX Quotation for New Employee Incentive Shares
Premium
Company Announcements
OncoSil Seeks ASX Quotation for New Employee Incentive Shares
1M ago
OncoSil Issues New Unquoted Options Under Employee Incentive Scheme
Premium
Company Announcements
OncoSil Issues New Unquoted Options Under Employee Incentive Scheme
1M ago
OncoSil Flags Isolated Administrative Lapse in Director Interest Disclosure
PremiumCompany AnnouncementsOncoSil Flags Isolated Administrative Lapse in Director Interest Disclosure
3M ago
OncoSil Medical Securities Reinstated to ASX Quotation
Premium
Company Announcements
OncoSil Medical Securities Reinstated to ASX Quotation
3M ago
OncoSil Raises Institutional Capital via Share Placement and Issues Cleansing Notice
Premium
Company Announcements
OncoSil Raises Institutional Capital via Share Placement and Issues Cleansing Notice
4M ago
OncoSil Medical Seeks ASX Quotation for New Shares and Options
PremiumCompany AnnouncementsOncoSil Medical Seeks ASX Quotation for New Shares and Options
4M ago
OncoSil Raises $2m in Fully Subscribed Entitlement Offer to Fund Cancer Device Expansion
Premium
Company Announcements
OncoSil Raises $2m in Fully Subscribed Entitlement Offer to Fund Cancer Device Expansion
4M ago
OncoSil shareholders back capital and remuneration resolutions at EGM
Premium
Company Announcements
OncoSil shareholders back capital and remuneration resolutions at EGM
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100